0001209191-21-035030.txt : 20210521
0001209191-21-035030.hdr.sgml : 20210521
20210521173549
ACCESSION NUMBER: 0001209191-21-035030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210521
FILED AS OF DATE: 20210521
DATE AS OF CHANGE: 20210521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAKIANATHAN DEEPIKA
CENTRAL INDEX KEY: 0001270734
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 21950359
MAIL ADDRESS:
STREET 1: 160 BOVET ROAD, SUITE 408
STREET 2: C/O DELPHI VENTURES
CITY: SAN MATEO
STATE: CA
ZIP: 94402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-658-0600
MAIL ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-21
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001270734
PAKIANATHAN DEEPIKA
C/O DELPHI VENTURES, 63 BOVET RD.
SUITE 351
SAN MATEO
CA
94402
1
0
0
0
Nonstatutory Stock Option (right to buy)
9.42
2021-05-21
4
A
0
23900
0.00
A
2031-05-20
Common Stock
23900
23900
D
This option vests as to 100% of the underlying shares on the earlier of May 21, 2022 or the next annual meeting of stockholders of Karyopharm Therapeutics Inc. (the "Issuer"), provided that the reporting person continues to serve as a director of the Issuer through such date.
/s/ Matthew T. Potter, Attorney-in-Fact for Deepika Pakianathan
2021-05-21